Journal article

Moving Toward Personalized Medicine Treatment-Focused Genetic Testing of Women Newly Diagnosed With Ovarian Cancer

Alison H Trainer, Bettina Meiser, Kaaren Watts, Gillian Mitchell, Kathy Tucker, Michael Friedlander

International Journal of Gynecological Cancer | LIPPINCOTT WILLIAMS & WILKINS | Published : 2010


OBJECTIVES: The presence of a germline BRCA mutation defines a genotype-specific group of women whose invasive ovarian cancer is associated with an increasingly well-defined prognostic and chemosensitivity biological profile. To determine the criteria that may be used to select patients for BRCA treatment-focused genetic testing, we performed a systemic literature search of studies that assessed BRCA1 and BRCA2 mutation frequency in women with ovarian cancer unselected for family history. The results are discussed with regard to the added clinical value gained by identifying a germline BRCA mutation at the time of the ovarian cancer diagnosis. METHODS: BRCA-related studies were identified in..

View full abstract